常用产品预处理烧伤创面时对菠萝蛋白酶酶性清创活性的抑制作用
本研究通过体外实验评估多种临床常用制剂及pH值对含菠萝蛋白酶酶混合物(NexoBrid®)清创效率的影响,以胶原真皮替代物(MatriDerm®)为底物观察消化情况。结果显示高浓度Prontosan®、低浓度Octenisept®、铜离子及磺胺嘧啶银可抑制NexoBrid®活性,铁剂未见完全抑制;作者推荐使用含聚己缩胍的Prontosan®冲洗预浸泡,避免银、铜制剂预处理。
要点
- 高浓度Prontosan®(≥50%)可抑制低浓度NexoBrid®(1.0 mg/ml)的酶活性。
- 铜100 µmol/L抑制低浓度(1.0 mg/ml)和高浓度(10 mg/ml)NexoBrid®活性。
- 作者推荐用含聚己缩胍的Prontosan®冲洗预浸泡,避免银、铜制剂预处理。
核心结论
- 作者推荐使用含聚己缩胍的Prontosan®冲洗和预浸泡烧伤创面。
- 作者建议避免使用含银和含铜的制剂预处理烧伤创面。
- 实验发现pH 3和11时NexoBrid®活性受到部分抑制。
研究设计与样本
- 体外研究,将胶原真皮替代物MatriDerm®暴露于NexoBrid®及不同浓度制剂中观察消化。
- 消化判断标准由3名研究者独立连续评估至少3次。
主要发现
- NexoBrid®浓度为1.0 mg/ml时,Prontosan®浓度≥50%对酶活性有影响。
- Octenisept®浓度≥10%时获得与Prontosan®类似的结果。
- 铜100 µmol/L抑制低浓度(1.0 mg/ml)和高浓度(10 mg/ml)NexoBrid®的酶活性。
- 磺胺嘧啶银在10%和90%浓度时抑制1 mg/ml NexoBrid®的活性。
- 任何浓度的铁均未导致NexoBrid®活性完全抑制。
临床怎么用
- 作者推荐使用含聚己缩胍的Prontosan®冲洗和预浸泡烧伤创面。
- 作者建议避免使用含银和含铜的制剂预处理烧伤创面。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An enzyme mixture containing bromelain (NexoBrid®) was found to be suitable for enzymatic debridement of burn wounds, as determined by the criteria of patient comfort and pain, selectivity, and efficiency. Nevertheless, daily experience showed that pretreatment of burn wounds with several other clinical agents may inhibit debridement efficiency. Therefore, the current study was performed to identify those agents and evaluate their debridement inhibition capabilities. The impact of several common agents as well pH, on NexoBrid® debridement efficiency was evaluated in vitro. A collagen-based dermal substitute (MatriDerm®) was exposed to NexoBrid® in the presence of different agents of varying concentrations. Digestion was documented. The criteria used for judging digestion were independently classified by 3 investigators at least 3 times in succession. When a low concentration (1.0 mg/ml) of NexoBrid® was used, a ≥ 50% concentration of Prontosan® had an impact on enzymatic activity. Comparable results were obtained when even lower concentrations of Octenisept® (≥ 10%) were used. A 100-µmol/L concentration of copper inhibited the enzymatic activity of both a low (1.0 mg/ml) and high (10 mg/ml) concentration of NexoBrid®. Silver-sulfadiazine at concentrations of 10% and 90% inhibited the activity of 1 mg/ml NexoBrid®. No complete inhibition of NexoBrid® activity occurred at any concentration of iron. We recommend using polyhexanide-containing agents (Prontosan®) to rinse and presoak burn wounds. Pretreatment of burn wounds with agents containing silver and copper should be avoided. Experimentally, we found a partial inhibition of NexoBrid® activity at the distinct pH values of 3 and 11.
引用
- Schulz A, Fuchs PC, Hans N, et al. Inhibition of Bromelain Activity During Enzymatic Debridement of Burn Wounds Pretreated With Frequently Used Products. J Burn Care Res. 2018. PMID: 29897542. doi:10.1097/BCR.0000000000000609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。